Rumble JR, Cooper ME, Cox AJ, Soulis T, Wu L, Youssef S, Jasik M, Jerums G, Gilbert RE: Vascular hypertrophy in experimental diabetes: Role of advanced glycation end products. J Clin Invest. 1997, 99 (5): 1016-1027.
Article
PubMed Central
CAS
PubMed
Google Scholar
Cooper ME, Rumble J, Komers R, Du HC, Jandeleit K, Chou ST: Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition. Diabetes. 1994, 43 (10): 1221-1228.
Article
CAS
PubMed
Google Scholar
Vranes D, Cooper ME, Dilley RJ: Cellular mechanisms of diabetic vascular hypertrophy. Microvascular Research. 1999, 57: 8-18. 10.1006/mvre.1998.2107.
Article
CAS
PubMed
Google Scholar
Gilbert RE, Rumble JR, Cao Z, Cox AJ, van Eeden P, Allen TJ, Kelly DJ, Cooper ME: Endothelin receptor antagonism ameliorates mast cell infiltration, vascular hypertrophy, and epidermal growth factor expression in experimental diabetes. Circ Res. 2000, 86: 158-165.
Article
CAS
PubMed
Google Scholar
Fukuda G, Khan ZA, Barbin YP, Farhangkhoee H, Tilton RG, Chakrabarti S: Endothelin-mediated remodeling in aortas of diabetic rats. Diabetes Metab Res Rev. 2005, 21 (4): 367-375. 10.1002/dmrr.527.
Article
CAS
PubMed
Google Scholar
Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003, 92 (8): 827-839. 10.1161/01.RES.0000070112.80711.3D.
Article
CAS
PubMed
Google Scholar
Ammarguellat FZ, Gannon PO, Amiri F, Schiffrin EL: Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors. Hypertension. 2002, 39 (2 Pt 2): 679-684. 10.1161/hy0202.103481.
Article
CAS
PubMed
Google Scholar
Ergul A, Portik-Dobos V, Giulumian AD, Molero MM, Fuchs LC: Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation. Am J Physiol Heart. 2003, 285 (5): H2225-2232.
Article
CAS
Google Scholar
Harris AK, Hutchinson JR, Sachidanandam K, Johnson MH, Dorrance AM, Stepp DW, Fagan SC, Ergul A: Type 2 diabetes causes remodeling of cerebrovasculature via differential regulation of matrix metalloproteinases and collagen synthesis: role of endothelin-1. Diabetes. 2005, 54 (9): 2638-2644.
Article
CAS
PubMed
Google Scholar
Portik-Dobos V, Harris AK, Song W, Hutchinson J, Johnson MH, Imig JD, Pollock DM, Ergul A: Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. Am J Physiol. 2006, 290 (2): R435-441.
CAS
Google Scholar
Standaert ML, Sajan MP, Miura A, Kanoh Y, Chen HC, Farese RV, Farese RV: Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states. J Biol Chem. 2004, 279 (24): 24929-24934. 10.1074/jbc.M402440200.
Article
CAS
PubMed
Google Scholar
Williams JM, Pollock JS, Pollock DM: Arterial pressure response to the antioxidant tempol and ETB receptor blockade in rats on a high-salt diet. Hypertension. 2004, 44 (5): 770-775. 10.1161/01.HYP.0000144073.42537.06.
Article
CAS
PubMed
Google Scholar
Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001, 98 (9): 5116-5121. 10.1073/pnas.091062498.
Article
PubMed Central
CAS
PubMed
Google Scholar
Galis ZS, Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002, 90 (3): 251-262.
CAS
PubMed
Google Scholar
Portik-Dobos V, Anstadt MP, Hutchinson J, Bannan M, Ergul A: Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes. Diabetes. 2002, 51: 3063-3068.
Article
CAS
PubMed
Google Scholar
Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP: Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients. Am J Hypertens. 2004, 17 (9): 775-782. 10.1016/j.amjhyper.2004.06.025.
Article
CAS
PubMed
Google Scholar
Rumble JR, Cooper ME, Soulis T, Cox A, Wu L, Youssef S, Jasik M, Jerums G, Gilbert RE: Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. J Clin Invest. 1997, 99 (5): 1016-1027.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gilbert RE, Cox A, McNally PG, Wu LL, Dziadek M, Cooper ME, Jerums G: Increased epidermal growth factor in experimental diabetes related kidney growth in rats. Diabetologia. 1997, 40 (7): 778-785. 10.1007/s001250050749.
Article
CAS
PubMed
Google Scholar
Wu S, Hopfner RL, McNeill JR, Wilson TW, Gopalakrishnan V: Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat. Cardiovasc Res. 2000, 45: 994-1000. 10.1016/S0008-6363(99)00417-4.
Article
CAS
PubMed
Google Scholar
Katakam PV, Pollock JS, Pollock DM, Ujhelyi MR, Miller AW: Enhanced endothelin-1 response and receptor expression in small mesenteric arteries of insulin-resistant rats. Am J Physiol. 2001, 280 (2): H522-527.
CAS
Google Scholar
Hattori Y, Kasai K, Nakamura T, Emodo T, Shimoda S-I: Effects of glucose and insulin on immunoreactive endothelin-1 release from cultured bovine endothelial cells. Metabolism. 1991, 40: 165-169. 10.1016/0026-0495(91)90168-V.
Article
CAS
PubMed
Google Scholar
Schroen B, Heymans S, Sharma U, Blankesteijn WM, Pokharel S, Cleutjens JP, Porter JG, Evelo CT, Duisters R, van Leeuwen RE: Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res. 2004, 95 (5): 515-522. 10.1161/01.RES.0000141019.20332.3e.
Article
CAS
PubMed
Google Scholar
Bornstein P, Agah A, Kyriakides TR: The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int J Biochem Cell Biol. 2004, 36 (6): 1115-1125. 10.1016/j.biocel.2004.01.012.
Article
CAS
PubMed
Google Scholar
Spinale FG: Cell-matrix signaling and thrombospondin: another link to myocardial matrix remodeling. Circ Res. 2004, 95 (5): 446-448. 10.1161/01.RES.0000142315.88477.42.
Article
CAS
PubMed
Google Scholar
Yang Z, Kyriakides TR, Bornstein P: Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2. Mol Biol Cell. 2000, 11 (10): 3353-3364.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE: Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol. 1998, 140 (2): 419-430. 10.1083/jcb.140.2.419.
Article
PubMed Central
CAS
PubMed
Google Scholar